What are the side effects of amlodipine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amlodipine Side Effects

Amlodipine's most common side effects are peripheral edema (occurring in 10.8% at 10mg dose), headache, flushing, and dizziness, with edema being dose-related and more frequent in women. 1

Most Common Side Effects (Dose-Related)

The FDA-approved labeling from controlled trials demonstrates clear dose-dependent adverse effects 1:

  • Peripheral edema: 1.8% (2.5mg), 3.0% (5mg), 10.8% (10mg) vs 0.6% placebo
  • Dizziness: 1.1% (2.5mg), 3.4% (5mg), 3.4% (10mg) vs 1.5% placebo
  • Flushing: 0.7% (2.5mg), 1.4% (5mg), 2.6% (10mg) vs 0% placebo
  • Palpitations: 0.7% (2.5mg), 1.4% (5mg), 4.5% (10mg) vs 0.6% placebo

Important caveat: Meta-analysis data reveals that approximately 37% of edema cases occurring on amlodipine may be unrelated to the drug itself, with the placebo-adjusted rate being 63%. 2

Common Non-Dose-Related Side Effects

Additional adverse effects occurring in >1% of patients include 1:

  • Fatigue: 4.5% vs 2.8% placebo
  • Nausea: 2.9% vs 1.9% placebo
  • Abdominal pain: 1.6% vs 0.3% placebo
  • Somnolence: 1.4% vs 0.6% placebo

The American College of Cardiology confirms headache, flushing, and dizziness as additional potential side effects. 3

Gender-Specific Differences

Women experience significantly higher rates of certain side effects compared to men 1:

  • Edema: 14.6% in women vs 5.6% in men (on amlodipine)
  • Flushing: 4.5% in women vs 1.5% in men
  • Palpitations: 3.3% in women vs 1.4% in men

Less Common But Clinically Important Side Effects

Occurring in <1% but >0.1% of patients 1:

Cardiovascular: Arrhythmia (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, peripheral ischemia, syncope, tachycardia, vasculitis

Neurological: Hypoesthesia, peripheral neuropathy, paresthesia, tremor, vertigo

Gastrointestinal: Anorexia, constipation, dysphagia, diarrhea, flatulence, pancreatitis, vomiting, gingival hyperplasia

Dermatologic: Angioedema, erythema multiforme, pruritus, rash (various types)

Hematologic: Leukopenia, purpura, thrombocytopenia

Serious Cardiovascular Considerations

Major side effects include hypotension, worsening heart failure, bradycardia, and AV block, as noted by the American Heart Association. 4

The European Society of Cardiology warns that all calcium channel blockers may precipitate heart failure in predisposed patients. 3 The American College of Cardiology recommends monitoring closely for signs of worsening heart failure, including increased dyspnea, weight gain, or edema. 5

Critical pitfall: Amlodipine should not be used as routine treatment for heart failure with reduced ejection fraction (HFrEF), though it may be considered for concurrent hypertension or angina as it has neutral effects on mortality. 5

Dose-Reduction Strategy for Side Effect Management

Using low to medium doses (2.5-5mg) significantly reduces side effect burden 2:

  • Lower rates of edema with 2.5-5mg (risk ratio: 2.01) compared to 10mg (risk ratio: 3.08)
  • Headache is actually reduced on amlodipine at low/medium doses (risk ratio: 0.52) vs placebo

Drug Interactions and Precautions

The American Heart Association warns that NSAIDs should be avoided in patients taking amlodipine for hypertension, as they worsen blood pressure control and may precipitate heart failure. 5

The American College of Cardiology advises against combining amlodipine with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) in heart failure patients, as these agents cause myocardial depression. 5

Overdose Management

In cases of amlodipine overdose, the American Heart Association recommends calcium administration, vasopressors, and high-dose insulin therapy may be required for severe toxicity. 5

Laboratory and Metabolic Effects

Amlodipine has not been associated with clinically significant changes in routine laboratory tests. No clinically relevant changes were noted in serum potassium, glucose, triglycerides, total cholesterol, HDL cholesterol, uric acid, blood urea nitrogen, or creatinine. 1

References

Guideline

Amlodipine Side Effects and Clinical Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amlodipine Pharmacology and Clinical Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.